| |
| |
|
| Insider
Information: |
Burgess Daniel D |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
22,593 |
|
|
Indirect Shares
|
3,000 |
|
|
| Direct
Value |
$26,432 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
25,593 |
|
|
| Total
Value |
$26,432 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Harbor Biosciences Inc |
HRBR |
COO/CFO |
2007-02-14 |
12,209 |
2006-02-13 |
0 |
Premium* |
|
|
Santarus Inc |
SNTS |
Director |
2013-06-03 |
0 |
2013-02-01 |
0 |
Premium* |
|
|
Cidara Therapeutics, Inc. |
CDTX |
Director |
2015-04-20 |
0 |
2015-04-20 |
3,000 |
Premium* |
|
|
Nabriva Therapeutics AG |
NBRV |
Director |
2022-08-02 |
10,384 |
2018-07-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NBRV |
Nabriva Therapeutics AG |
Director |
– • – |
2022-08-02 |
4 |
S |
$0.19 |
$2,156 |
D/D |
(11,341) |
10,384 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Director |
– • – |
2021-08-02 |
4 |
S |
$1.20 |
$1,350 |
D/D |
(1,125) |
21,725 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Director |
– • – |
2021-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
17,500 |
22,850 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Director |
– • – |
2020-07-29 |
4 |
A |
$0.00 |
$0 |
D/D |
17,500 |
53,500 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Director |
– • – |
2018-07-31 |
4 |
B |
$2.75 |
$99,000 |
D/D |
36,000 |
36,000 |
2.39 |
- |
|
| CDTX |
Cidara Therapeutics, Inc. |
Director |
– • – |
2015-04-20 |
4 |
B |
$16.00 |
$48,000 |
I/I |
3,000 |
3,000 |
2.1 |
- |
|
| SNTS |
Santarus Inc |
Director |
– • – |
2013-06-03 |
4 |
AS |
$21.34 |
$170,726 |
D/D |
(8,000) |
0 |
0 |
- |
|
| SNTS |
Santarus Inc |
Director |
– • – |
2013-06-03 |
4 |
OE |
$3.00 |
$24,000 |
D/D |
8,000 |
8,000 |
0 |
- |
|
| SNTS |
Santarus Inc |
Director |
– • – |
2013-05-01 |
4 |
AS |
$17.88 |
$143,047 |
D/D |
(8,000) |
0 |
0 |
- |
|
| SNTS |
Santarus Inc |
Director |
– • – |
2013-05-01 |
4 |
OE |
$3.00 |
$24,000 |
D/D |
8,000 |
8,000 |
0 |
- |
|
| SNTS |
Santarus Inc |
Director |
– • – |
2013-04-01 |
4 |
AS |
$17.47 |
$139,774 |
D/D |
(8,000) |
0 |
0 |
- |
|
| SNTS |
Santarus Inc |
Director |
– • – |
2013-04-01 |
4 |
OE |
$1.18 |
$16,720 |
D/D |
8,000 |
8,000 |
0 |
- |
|
| SNTS |
Santarus Inc |
Director |
– • – |
2013-03-01 |
4 |
AS |
$13.37 |
$106,954 |
D/D |
(8,000) |
0 |
0 |
- |
|
| SNTS |
Santarus Inc |
Director |
– • – |
2013-03-01 |
4 |
OE |
$1.18 |
$9,440 |
D/D |
8,000 |
8,000 |
0 |
- |
|
| SNTS |
Santarus Inc |
Director |
– • – |
2013-02-01 |
4 |
AS |
$13.28 |
$106,245 |
D/D |
(8,000) |
0 |
0 |
- |
|
| SNTS |
Santarus Inc |
Director |
– • – |
2013-02-01 |
4 |
OE |
$1.18 |
$9,440 |
D/D |
8,000 |
8,000 |
0 |
- |
|
| HRBR |
Harbor Biosciences Inc |
COO/CFO |
• – – |
2007-02-14 |
4 |
AS |
$5.49 |
$12,377 |
D/D |
(2,250) |
12,209 |
0 |
- |
|
| HRBR |
Harbor Biosciences Inc |
COO & CFO |
• – – |
2006-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
13,256 |
|
- |
|
18 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
